UK Markets closed

Evonik Industries AG (0QDS.IL)

IOB - IOB Delayed price. Currency in EUR
Add to watchlist
19.11-0.03 (-0.13%)
At close: 05:59PM GMT
Full screen
Previous close19.14
Bid18.64 x 0
Ask19.59 x 0
Day's range18.93 - 19.18
52-week range16.55 - 29.72
Avg. volume355,540
Market cap8.919B
Beta (5Y monthly)1.26
PE ratio (TTM)12.49
Earnings dateN/A
Forward dividend & yield1.17 (6.33%)
Ex-dividend date27 May 2022
1y target estN/A
  • Simply Wall St.

    Evonik Industries AG Just Beat Revenue By 11%: Here's What Analysts Think Will Happen Next

    Evonik Industries AG ( ETR:EVK ) investors will be delighted, with the company turning in some strong numbers with its...

  • Simply Wall St.

    Evonik Industries Third Quarter 2022 Earnings: Beats Expectations

    Evonik Industries ( ETR:EVK ) Third Quarter 2022 Results Key Financial Results Revenue: €4.88b (up 26% from 3Q 2021...

  • Reuters

    Germany's Evonik expects 2022 earnings to rise despite economic weakening

    (Reuters) -German chemicals group Evonik Industries, which makes ingredients for Pfizer/BioNTech's COVID-19 vaccine, on Tuesday said it expected a rise in 2022 earnings despite a weakening economy, after third-quarter profit broadly met expectations. The company, which also makes ingredients for animal feed and diapers, sees full-year adjusted earnings before interest, taxes, depreciation and amortisation (EBITDA) between 2.5 billion to 2.6 billion euros, above the 2021 figure of 2.38 billion euros. She noted that raw material and logistic costs have started to fall as supply challenges eased and that maintaining attractive price levels in a slowing environment would be the next proof of Evonik's specialty portfolio.